AstraZeneca crisis proves short-lived
Some argue that Ireland’s prudence in suspending rollout over the blood clot issue will boost public confidence in vaccination. Others say it may cost lives
One of the biggest pitfalls in data analysis is distinguishing between correlation and causation. Often, when no concrete answer can be given, it is best to simply acknowledge the correlation but caveat the many possible linked causes.
When the European Medicines Agency (EMA) was faced with widespread panic over blood clots in a small number of recently vaccinated individuals across Europe last week, it took five days for it to publish a similar conclusion.
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
We’re winning the numbers game, but it is not all over yet
The drop in case numbers already exceeds predictions, but there is still work to do to reach herd immunity – and to keep an eye on those variants
Analysis: Hope rises as 2 million vaccines administered
A quarter of a million doses are expected to be administered this week, increasing to between 260,000 and 280,000 next week
Supermarkets rule out antigen test sale after Lidl controversy
Supervalu and Aldi say they have no plans to sell the rapid testing kits after public health officials rebuke Lidl